Package Leaflet: Information for the Patient
Dimethyl Fumarate Dr. Reddys 120 mg Hard Gastro-Resistant Capsules EFG
Dimethyl Fumarate Dr. Reddys 240 mg Hard Gastro-Resistant Capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Dimethyl Fumarate Dr. Reddys is a medicine that contains dimethyl fumarateas the active substance.
Dimethyl Fumarateis used to treat multiple sclerosis (MS) in patients from 13 years of age and older with relapsing-remitting MS.
MS is a long-term disease that affects the central nervous system (CNS), which includes the brain and spinal cord. Relapsing-remitting MS is characterized by repeated attacks (relapses) of neurological symptoms. Symptoms vary from person to person but often include: difficulty walking, balance problems, and vision problems (e.g., blurred or double vision). These symptoms can disappear completely when the relapse is over, but some problems may remain.
This medicine seems to work by preventing the body's defense system from damaging the brain and spinal cord. This may also help to delay future disability in MS.
Warnings and precautions
Dimethyl Fumarate may affect your white blood cell count, kidneys, and liver. Before starting dimethyl fumarate, your doctor will perform a blood test to get a white blood cell count and check that your kidneys and liver are working properly. Your doctor will perform periodic tests during treatment. If you have a low white blood cell count during treatment, your doctor may consider additional tests or interrupt your treatment.
Consult your doctorbefore starting dimethyl fumarate if you have:
Herpes zoster (shingles) may occur during treatment with dimethyl fumarate. In some cases, serious complications have occurred. You must inform your doctor immediatelyif you suspect that you have any symptoms of shingles.
If you think that your MS is getting worse (e.g., weakness or changes in vision) or if you notice any new symptoms, talk to your doctor directly, as they could be symptoms of a rare brain infection called PML. PML is a serious disease that can cause death or severe disability.
A rare but serious kidney disorder called Fanconi syndrome has been reported with a medicine that contains dimethyl fumarate in combination with other fumaric acid esters, used to treat psoriasis (a skin disease). If you notice that you are urinating more, are thirstier, and drink more than usual, your muscles seem weaker, you break a bone, or simply have pains and discomfort, inform your doctor as soon as possible so that this can be investigated further.
Do not give this medicine to children under 10 years of age because there is no data available for this age group.
Tell your doctor or pharmacistif you are taking, have recently taken, or might take any other medicines, in particular:
After taking dimethyl fumarate, you should avoid consuming more than a small amount (more than 50 ml) of strong alcoholic beverages (with an alcohol content of more than 30%, such as liqueurs) for the first hour because alcohol may interact with this medicine. This may cause stomach inflammation (gastritis), especially in people who are prone to this condition.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Information on the effects of this medicine when used during pregnancy is limited. Do not take dimethyl fumarate during pregnancy unless you have discussed this with your doctor and this medicine is clearly necessary for you.
Breastfeeding
It is not known if the active substance of dimethyl fumarate passes into breast milk. Your doctor will inform you whether you should stop breastfeeding, or stop taking dimethyl fumarate. This decision involves weighing the benefits of breastfeeding for your child and the benefits of treatment for you.
Dimethyl fumarate is not expected to affect your ability to drive and use machines.
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially “sodium-free”.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, ask your doctor again.
Take this starting dose for the first 7 days, then take the usual dose.
Dimethyl Fumarate is taken orally.
The capsules should be swallowed whole, with some water. Do not break, crush, dissolve, or chew the capsules because this may increase some side effects.
Take Dimethyl Fumarate Dr. Reddys with food– this helps to reduce some of the very common side effects (listed in section 4).
If you take too many capsules, inform your doctor immediately. You may experience side effects similar to those described below in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
Do not take a double dose to make up for forgotten doses. You can take the forgotten dose if at least 4 hours have passed between doses. Otherwise, wait until the next dose.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Dimethyl Fumarate may decrease your lymphocyte count (a type of white blood cell). A low white blood cell count can increase the risk of infection, including a rare brain infection called progressive multifocal leukoencephalopathy (PML). PML can cause death or severe disability. PML has occurred after 1 to 5 years of treatment, so your doctor will continue to monitor your white blood cells during treatment, and you should remain alert to any possible symptoms of PML, as described below. The risk of PML may be higher if you have previously taken a medicine that has made your immune system weaker.
The symptoms of PML can be similar to those of an MS relapse. Symptoms can include new or worsening weakness on one side of the body; clumsiness; changes in vision, thinking, or memory; or confusion or personality changes, or difficulty speaking and communicating that may persist for more than several days. Therefore, it is very important that you talk to your doctor as soon as possible if you think that your MS is getting worse or if you notice any new symptoms while being treated with Dimethyl Fumarate Dr. Reddys. Also, inform your partner or caregivers about your treatment. It is possible that symptoms may arise that you are not aware of on your own.
The frequency of severe allergic reactions cannot be estimated from the available data (frequency not known).
Facial or body redness (flushing) is a very common side effect.However, if the redness is accompanied by a rash or hivesandyou have any of the following symptoms:
this could be a severe allergic reaction (anaphylaxis).
Very common(may affect more than 1 in 10 people)
Taking the medicine with foodmay help reduce the above side effects
While being treated with dimethyl fumarate, it is common for urine tests to show the presence of ketones, substances that are naturally produced by the body.
Consult your doctorabout how to treat these side effects. Your doctor may reduce your dose. Do not reduce the dose unless your doctor tells you to.
Common(may affect up to 1 in 10 people)
Side effects that may appear in blood or urine tests
Uncommon(may affect up to 1 in 100 people)
Frequency not known(cannot be estimated from the available data)
The side effects described above also apply to children and adolescents.
Some side effects were reported more frequently in children and adolescents than in adults,
If you experience any side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return the containers and any unused medicines to the pharmacy. Ask your pharmacist how to dispose of containers and unused medicines. This will help protect the environment.
The active substanceis dimethyl fumarate.
Dimethyl Fumarate Dr. Reddys 120 mg: each capsule contains 120 mg of dimethyl fumarate.
Dimethyl Fumarate Dr. Reddys 240 mg: each capsule contains 240 mg of dimethyl fumarate.
The other ingredientsare microcrystalline cellulose (E460), sodium croscarmellose (E468), povidone K30, talc (E553b), magnesium stearate (E1505), methacrylic acid - methyl methacrylate copolymer (1:1) (E1205), sodium lauryl sulfate (E470a), triethyl citrate (E1505), methacrylic acid - ethyl acrylate copolymer (1:1) dispersion 30% (E1205), polysorbate 80 (E433), gelatin, titanium dioxide (E171), brilliant blue FCF (E133), yellow iron oxide (E172), shellac, potassium hydroxide, and black iron oxide (E172).
Dimethyl Fumarate Dr. Reddys 120 mg hard gastro-resistant capsules (size 1, approximately 19.3 mm) are green and white and are printed with “RDY” on the cap and “429” on the body.
Each blister contains 14 or 56 capsules.
Each single-dose blister contains 14 x 1 capsules.
Dimethyl Fumarate Dr. Reddys 240 mg hard gastro-resistant capsules (size 0, approximately 21.4 mm) are green and are printed with “RDY” on the cap and “430” on the body.
Each blister contains 14, 56, 112, 168, or 196 capsules.
Each single-dose blister contains 56 x 1 capsules.
Not all pack sizes may be marketed.
Manufacturer
betapharm Arzneimittel GmbH,
Kobelweg 95,
86156 Augsburg
Germany
or
Pharmadox Healthcare Ltd.,
KW20A Kordin Industrial Park
Paola PLA 3000
Malta
or
Rual Laboratories SRL
313, Splaiul Unirii, Building H
1st floor, sector 3
030138 Bucharest
Romania
or
Laboratori Fundacio Dau,
Calle Lletra C De La Zona Franca, 12-14,
Poligono Industrial De La Zona Franca De Barcelona,
Barcelona, 08040,
Spain.
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Country | Name |
Austria | Dimethylfumarat Reddy 120 mg gastro-resistant hard capsules Dimethylfumarat Reddy 240 mg gastro-resistant hard capsules |
Czech Republic | Dimethyl fumarate Reddy 120 mg enteric-coated hard capsules Dimethyl fumarate Reddy 240 mg enteric-coated hard capsules |
Germany | Dimethylfumarat beta 120 mg gastro-resistant hard capsules Dimethylfumarat beta 240 mg gastro-resistant hard capsules |
Spain | Fumarato de Dimetilo Dr. Reddys 120 mg gastro-resistant hard capsules EFG Fumarato de Dimetilo Dr. Reddys 240 mg gastro-resistant hard capsules EFG |
Italy | Dimetilfumarato Dr. Reddy’s 120 mg gastro-resistant hard capsules Dimetilfumarato Dr. Reddy’s 240 mg gastro-resistant hard capsules |
Netherlands | Dimethylfumaraat Reddy 120 mg gastro-resistant hard capsules Dimethylfumaraat Reddy 240 mg gastro-resistant hard capsules |
Poland | Dimethyl fumarate Reddy 120 mg enteric-coated hard capsules Dimethyl fumarate Reddy 240 mg enteric-coated hard capsules |
Portugal | Dimethyl fumarate Reddy 120 mg gastro-resistant capsules Dimethyl fumarate Reddy 240 mg gastro-resistant capsules |
Romania | Dimetil fumarat Dr. Reddy’s 120 mg gastro-resistant capsules Dimetil fumarat Dr. Reddy’s 240 mg gastro-resistant capsules |
Sweden | Dimethyl fumarate Reddy 120 mg enteric-coated hard capsules Dimethyl fumarate Reddy 240 mg enteric-coated hard capsules |
Slovakia | Dimethyl fumarate Reddy 120 mg gastro-resistant hard capsules Dimethyl fumarate Reddy 240 mg gastro-resistant hard capsules |
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/